Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Pharma 5.0
Company News
Events
Directory
Search
Close search
Home
Company
Actavis
Actavis
Activities:
Manufacturing
Pharmaceutical
X
LinkedIn
Trending Articles
Agilent boosts contract manufacturing capabilities with acquisition of BIOVECTRA
The CDMO acquisition will bolster Agilent's end-to-end production capabilities in a number of popular therapeutics, including GLP-1 medications and ADCs
KBI Biopharma extends contract with a big pharma giant after a successful FDA inspection
The contract has been renewed and extended until at least 2029, and will now include the purchase of two therapeutic products
Currax to build novel anti-obesity treatment production facility amidst GLP-1 supply issues
The manufacturing facility will be dedicated to the production of anti-obesity drug Contrave, and will double its output in the EU and EEA
New FAIRY viral assay could 'revolutionise' the response to future pandemics
The assay, which can detect the infectiousness of a virus in a matter of minutes, offers a quicker and cheaper alternative to the standard cell culture approach
New advice from BOLA and Labtex on cleaning and handling of PTFE products after use
The companies share: "Abrasive scouring agents may result in a milkiness of the vessels made of PFA and FEP. You may use all neutral detergents (pH 7). For higher contamination...
Upcoming event
ISPE Singapore
28-30 August 2024 | Conference and exhibition | Singapore
See all
Related Content
Regulatory
Pharma companies fined £45m for 'pay-for-delay'
GSK’s conduct, in making payments to induce companies to delay their efforts to enter the UK paroxetine market infringed the competition law prohibition on abuse of a dominant position
Regulatory
Schizophrenia – cariprazine
Drug treatment for schizophrenia has relied for many years on antipsychotics such as chlorpromazine and haloperidol, but side-effects limited their usefulness, particularly in terms of compliance
Finance
Amneal to purchase generics business of Actavis Australia
Financial terms are not disclosed by the companies
Regulatory
Actavis gets go-ahead from European Commission to purchase Allergan
Deal will create one of the top 10 global pharmaceutical companies by sales revenue
Finance
Actavis plans to change name to Allergan after acquisition closes
Will retain Actavis name for certain geographic regions and product portfolios
Research & Development
Actavis to divest Pharmatech to TPG
TPG to focus on growth and development of innovative products
Regulatory
Nearly 90,000 Gabapentin capsules are recalled by Aurobindo Pharma and Actavis
The capsules were manufactured at two plants in India
Subscribe now